Gregory P Forlenza (Greg Forlenza, Gregory Forlenza)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 64

Top Venues

Diabetes technology & therapeutics

Diabetes care

Journal of pediatric hematology/oncology

Pediatric diabetes

Barbara Davis Center for Childhood Diabetes

University of Minnesota Twin Cities (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Barbara Davis Center for Childhood Diabetes

United States

Assistant Professor :: Pediatric Endocrinology

University of Florida

United States

Assistant Professor :: General Pediatrics

Education History

University of Minnesota Twin Cities

United States

MSC :: Public Health/Clinical Research

Georgia Institute of Technology

United States

BSC :: Chemistry

Publications

Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics (2024)
Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics 26 (4) (2024)
Gregory P Forlenza, Zheng Dai, Fang Niu, John J Shin
Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems. Diabetes technology & therapeutics 26 (S3) (2024)
Neil J Khatter, Stephanie W Hum, Jacob A Mark, Gregory P Forlenza, Taylor M Triolo
Longitudinal Quality of Life and Glycemic Outcomes of Total Pancreatectomy With Islet Autotransplantation in Children With Chronic Pancreatitis Followed in a Pediatric Multidisciplinary Pancreas Clinic. Pediatric transplantation 28 (5) (2024)
Lauren A Waterman, Laura Pyle, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa, Erin C Cobry
Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes technology & therapeutics 26 (9) (2024)
Gregory P Forlenza, Ideen Tabatabai, Dana Michelle Lewis
Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management. Diabetes technology & therapeutics (2024)
Erin C Cobry, Laura Pyle, Lauren A Waterman, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa
Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions. Diabetes technology & therapeutics 26 (2) (2024)
Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, Lori M B Laffel, Bruce A Buckingham, Amy B Criego, Melissa Schoelwer, Sarah A MacLeish, Jennifer L Sherr, David W Hansen, Trang T Ly
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod ® 5 Automated Insulin Delivery System. Diabetes technology & therapeutics 26 (6) (2024)
Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, Lori M B Laffel, Bruce A Buckingham, Amy B Criego, Melissa Schoelwer, Sarah A MacLeish, Jennifer L Sherr, David W Hansen, Trang T Ly
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod ® 5 Automated Insulin Delivery System. Diabetes technology & therapeutics 26 (6) (2024)
Carol J Levy, Ryan J Bailey, Lori M B Laffel, Gregory P Forlenza, Linda A DiMeglio, Michael S Hughes, Sue A Brown, Grazia Aleppo, Anuj Bhargava, Viral N Shah, Mark A Clements, Mark Kipnes, Brittany S Bruggeman, Mark Daniels, Henry Rodriguez, Peter Calhoun, John W Lum, Ravid Sasson-Katchalski, Jordan E Pinsker, Robyn Pollom, Roy W Beck, null null
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes. Diabetes technology & therapeutics (2024)
Carol J Levy, Ryan J Bailey, Lori M B Laffel, Gregory P Forlenza, Linda A DiMeglio, Michael S Hughes, Sue A Brown, Grazia Aleppo, Anuj Bhargava, Viral N Shah, Mark A Clements, Mark Kipnes, Brittany S Bruggeman, Mark Daniels, Henry Rodriguez, Peter Calhoun, John W Lum, Ravid Sasson-Katchalski, Jordan E Pinsker, Robyn Pollom, Roy W Beck, null null
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes. Diabetes technology & therapeutics 26 (9) (2024)
Gregory P Forlenza, Daniel J DeSalvo, Grazia Aleppo, Emma G Wilmot, Cari Berget, Lauren M Huyett, Irene Hadjiyianni, José J Méndez, Lindsey R Conroy, Trang T Ly, Jennifer L Sherr
Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes technology & therapeutics 26 (8) (2024)
Gregory P Forlenza, Jennifer L Sherr
Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations. Diabetes technology & therapeutics (2024)
Neil J Khatter, Stephanie W Hum, Jacob A Mark, Gregory P Forlenza, Taylor M Triolo
Longitudinal Quality of Life and Glycemic Outcomes of Total Pancreatectomy With Islet Autotransplantation in Children With Chronic Pancreatitis Followed in a Pediatric Multidisciplinary Pancreas Clinic. Pediatric transplantation 28 (5) (2024)
Viral N Shah, Lauren G Kanapka, Halis Kaan Akturk, Sarit Polsky, Gregory P Forlenza, Craig Kollman, Roy W Beck, Janet K Snell-Bergeon
Time in Range Is Associated with Incident Diabetic Retinopathy in Adults with Type 1 Diabetes: A Longitudinal Study. Diabetes technology & therapeutics 26 (4) (2024)
Lauren A Waterman, Laura Pyle, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa, Erin C Cobry
Accuracy of a Real-Time Continuous Glucose Monitor in Pediatric Diabetic Ketoacidosis Admissions. Diabetes technology & therapeutics (2024)
Erin C Cobry, Laura Pyle, Lauren A Waterman, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa
Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions. Diabetes technology & therapeutics (2024)
Daniel J DeSalvo, Bruce W Bode, Gregory P Forlenza, Lori M B Laffel, Bruce A Buckingham, Amy B Criego, Melissa Schoelwer, Sarah A MacLeish, Jennifer L Sherr, David W Hansen, Trang T Ly
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod ® 5 Automated Insulin Delivery System. Diabetes technology & therapeutics (2024)
Gregory P Forlenza, Daniel J DeSalvo, Grazia Aleppo, Emma G Wilmot, Cari Berget, Lauren M Huyett, Irene Hadjiyianni, José J Méndez, Lindsey R Conroy, Trang T Ly, Jennifer L Sherr
Real-World Evidence of Omnipod ® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes technology & therapeutics (2024)
Erin C Cobry, Laura Pyle, Lauren A Waterman, Gregory P Forlenza, Lindsey Towers, Angela J Karami, Emily Jost, Cari Berget, R Paul Wadwa
Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions. Diabetes technology & therapeutics 26 (2) (2024)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology 45 (2) (2023)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology (2023)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology 45 (2) (2023)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology 45 (2) (2023)
Ho Man Colman Leung, Gregory P Forlenza, Temiloluwa O Prioleau, Xia Zhou
Noninvasive Glucose Sensing In Vivo. Sensors (Basel, Switzerland) 23 (16) (2023)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology 45 (2) (2023)
Rebecca Baqiyyah Conway, Andrea Gerard Gonzalez, Viral N Shah, Cristy Geno Rasmussen, Halis Kaan Akturk, Laura Pyle, Gregory P Forlenza, Guy Todd Alonso, Janet Snell-Bergeon
Racial Disparities in Diabetes Technology Adoption and Their Association with HbA1c and Diabetic Ketoacidosis. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Jenna M Sopfe, Sharon Scarbro, Krithika Suresh, Kelly Maloney, Gregory P Forlenza
Hyperglycemia and Other Glycemic Measures Throughout Therapy for Pediatric Acute Lymphoblastic Leukemia and Lymphoma. Journal of pediatric hematology/oncology 45 (2) (2023)
Laurel H Messer, Paul F Cook, Stephen Voida, Casey Fiesler, Emily Fivekiller, Chinmay Agrawal, Tian Xu, Gregory P Forlenza, Sriram Sankaranarayanan
Situational Awareness and Proactive Engagement Predict Higher Time in Range in Adolescents and Young Adults Using Hybrid Closed-Loop. Pediatric diabetes 2023 (2023)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Gregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, Larry A Fox, Henry Rodriguez, Dorothy I Shulman, Kevin B Kaiserman, David R Liljenquist, John Shin, Scott W Lee, Bruce A Buckingham
Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial. Pediatric diabetes 23 (3) (2022)
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David C Klonoff, David T Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jefferie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg D Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre Yves Benhamou, B Wayne Bequette, Thomas Blevins, Marc D Breton, Jessica R Castle, James Geoffrey Chase, Kong Y Chen, Pratik Choudhary, Mark A Clements, Kelly L Close, Curtiss B Cook, Thomas Danne, Francis J Doyle Iii, Andjela T Drincic, Kathleen M Dungan, Steven V Edelman, Niels Ejskjær, Juan C Espinoza, G Alexander Fleming, Gregory P Forlenza, Guido Freckmann, Rodolfo J Galindo, Ana Maria Gómez, Hanna A Gutow, Lutz Heinemann, Irl B Hirsch, Thanh Duc Hoang, Roman Hovorka, Johan H Jendle, Li-Nong Ji, Shashank R Joshi, Michael Joubert, Suneil K Koliwad, Rayhan A Lal, M Cecilia Lansang, Wei-An Andy Lee, Lalantha Leelarathna, Lawrence Alan Leiter, Marcus Lind, Michelle L Litchman, Julia Katharina Mader, Katherine M Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Nicolas Mathioudakis, Alexander Y Mayorov, Jordan Messler, Joshua D Miller, Viswanathan Mohan, James H Nichols, Kirsten Nørgaard, David Norman O'Neal, Francisco J Pasquel, Athena Philis-Tsimikas, Thomas R Pieber, Moshe Phillip, William H Polonsky, Pradipta R Ray, Gerry Rayman, Eun Jung Rhee, Steven J Russell, Viral N Shah, Jennifer L Sherr, Koji Sode, Elias K Spanakis, Deborah J Wake, Kayo Waki, Amisha Wallia, Melissa E Weinberg, Howard Wolpert, Eugene E Wright, Mihail Zilbermint, Boris P Kovatchev
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of diabetes science and technology (2022)
Alexandra Sawyer, Marisa Sobczak, Gregory P Forlenza, Guy Todd Alonso
Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes. Diabetes technology & therapeutics 24 (6) (2022)
Gregory P Forlenza, Anders L Carlson, Rodolfo J Galindo, Davida F Kruger, Carol J Levy, Janet B McGill, Guillermo Umpierrez, Grazia Aleppo
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations. Diabetes technology & therapeutics 24 (11) (2022)
Meghan E Pauley, Kalie L Tommerdahl, Janet K Snell-Bergeon, Gregory P Forlenza
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits. Current cardiology reports (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Gregory P Forlenza, Rayhan A Lal
Current Status and Emerging Options for Automated Insulin Delivery Systems. Diabetes technology & therapeutics 24 (5) (2022)
Cari Berget, Jennifer L Sherr, Daniel J DeSalvo, Ryan S Kingman, Sheri L Stone, Sue A Brown, Alex Nguyen, Leslie Barrett, Trang T Ly, Gregory P Forlenza
Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes. Clinical diabetes : a publication of the American Diabetes Association 40 (2) (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Rodolfo J Galindo, Grazia Aleppo, Christopher G Parkin, David A Baidal, Anders L Carlson, Eda Cengiz, Gregory P Forlenza, Davida F Kruger, Carol J Levy, Janet B McGill, Guillermo E Umpierrez
Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria. Journal of diabetes science and technology (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Laurel H Messer, Cari Berget, Sophia Centi, Bryan Mcnair, Gregory P Forlenza
Evaluation of a New Clinical Tool to Enhance Clinical Care of Control-IQ Users. Journal of diabetes science and technology (2022)
Soohee Cho, Timothy Vigers, Laura Pyle, Anna Franklin, Jenna M Sopfe, Frankie Jeney, Gregory P Forlenza
Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes technology & therapeutics 25 (2) (2022)
Laurel H Messer, Bruce A Buckingham, Fran Cogen, Mark Daniels, Gregory P Forlenza, Rabab Z Jafri, Nelly Mauras, Andrew Muir, R Paul Wadwa, Perrin C White, Steven J Russell, Edward R Damiano, Firas H El-Khatib, Katrina J Ruedy, Courtney A Balliro, Zoey Li, Martin Chase Marak, Peter Calhoun, Roy W Beck
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes technology & therapeutics 24 (10) (2022)
Gregory P Forlenza, Marc D Breton, Boris P Kovatchev
Candidate Selection for Hybrid Closed Loop Systems. Diabetes technology & therapeutics 23 (11) (2021)
Gregory P Forlenza, Timothy Vigers, Cari Berget, Laurel H Messer, Rayhan A Lal, Marina Basina, David M Maahs, Korey K Hood, Bruce Buckingham, Darrell M Wilson, R Paul Wadwa, Kimberly A Driscoll, Laura Pyle
Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study. Diabetes technology & therapeutics (2021)
Laurel H Messer, Cari Berget, Ashlee Ernst, Lindsey Towers, Robert H Slover, Gregory P Forlenza
Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatric diabetes 22 (4) (2021)
Grazia Aleppo, Christopher G Parkin, Anders L Carlson, Rodolfo J Galindo, Davida F Kruger, Carol J Levy, Guillermo E Umpierrez, Gregory P Forlenza, Janet B McGill
Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion. Diabetes technology & therapeutics 23 (10) (2021)
Meghan E Pauley, Cari Berget, Laurel H Messer, Gregory P Forlenza
Barriers to Uptake of Insulin Technologies and Novel Solutions. Medical devices (Auckland, N.Z.) 14 (2021)
Laurel H Messer, Cari Berget, Laura Pyle, Timothy Vigers, Erin C Cobry, Kimberly A Driscoll, Gregory P Forlenza
Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes technology & therapeutics 23 (12) (2021)
Laurel H Messer, Cari Berget, Timothy Vigers, Laura Pyle, Cristy Geno, R Paul Wadwa, Kimberly A Driscoll, Gregory P Forlenza
Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatric diabetes 21 (2) (2020)
Cari Berget, Samantha Lange, Laurel Messer, Gregory P Forlenza
A clinical review of the t:slim X2 insulin pump. Expert opinion on drug delivery 17 (12) (2020)
Jenna M Sopfe, Laura L Pyle, Amy K Keating, Kristen R Miller, Arthur K Liu, R Paul Wadwa, Michael R Verneris, Roger H Giller, Gregory P Forlenza
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients. Blood advances 3 (3) (2020)
Lauren G Kanapka, R Paul Wadwa, Marc D Breton, Katrina J Ruedy, Laya Ekhlaspour, Gregory P Forlenza, Eda Cengiz, Melissa J Schoelwer, Emily Jost, Lori Carria, Emma Emory, Liana J Hsu, Stuart A Weinzimer, Mark D DeBoer, Bruce A Buckingham, Mary Oliveri, Craig Kollman, Betsy B Dokken, Daniel Cherñavvsky, Roy W Beck, null null
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes care 44 (2) (2020)
Sue A Brown, Roy W Beck, Dan Raghinaru, Bruce A Buckingham, Lori M B Laffel, R Paul Wadwa, Yogish C Kudva, Carol J Levy, Jordan E Pinsker, Eyal Dassau, Francis J Doyle Iii, Louise Ambler-Osborn, Stacey M Anderson, Mei Mei Church, Laya Ekhlaspour, Gregory P Forlenza, Camilla Levister, Vinaya Simha, Marc D Breton, Craig Kollman, John W Lum, Boris P Kovatchev, null null
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial. Diabetes care 43 (8) (2020)
Boris Kovatchev, Stacey M Anderson, Dan Raghinaru, Yogish C Kudva, Lori M B Laffel, Carol Levy, Jordan E Pinsker, R Paul Wadwa, Bruce Buckingham, Francis J Doyle Iii, Sue A Brown, Mei Mei Church, Vikash Dadlani, Eyal Dassau, Laya Ekhlaspour, Gregory P Forlenza, Elvira Isganaitis, David W Lam, John W Lum, Roy W Beck, null null
Randomized Controlled Trial of Mobile Closed-Loop Control. Diabetes care 43 (3) (2020)
Cari Berget, Laurel H Messer, Timothy Vigers, Brigitte I Frohnert, Laura Pyle, R Paul Wadwa, Kimberly A Driscoll, Gregory P Forlenza
Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatric diabetes 21 (2) (2020)
Aria Saunders, Laurel H Messer, Gregory P Forlenza
MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy. Expert review of medical devices 16 (10) (2019)
Gregory P Forlenza, Zoey Li, Bruce A Buckingham, Jordan E Pinsker, Eda Cengiz, R Paul Wadwa, Laya Ekhlaspour, Mei Mei Church, Stuart A Weinzimer, Emily Jost, Tatiana Marcal, Camille Andre, Lori Carria, Vance Swanson, John W Lum, Craig Kollman, William Woodall, Roy W Beck
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Diabetes care 41 (10) (2018)
Laurel H Messer, Gregory P Forlenza, Jennifer L Sherr, R Paul Wadwa, Bruce A Buckingham, Stuart A Weinzimer, David M Maahs, Robert H Slover
Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System. Diabetes care 41 (4) (2018)
Marc D Breton, Daniel R Cherñavvsky, Gregory P Forlenza, Mark D DeBoer, Jessica Robic, R Paul Wadwa, Laurel H Messer, Boris P Kovatchev, David M Maahs
Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study. Diabetes care 40 (12) (2017)
Gregory P Forlenza, Sunil Deshpande, Trang T Ly, Daniel P Howsmon, Faye Cameron, Nihat Baysal, Eric Mauritzen, Tatiana Marcal, Lindsey Towers, B Wayne Bequette, Lauren M Huyett, Jordan E Pinsker, Ravi Gondhalekar, Francis J Doyle, David M Maahs, Bruce A Buckingham, Eyal Dassau
Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes care 40 (8) (2017)

Gregory P Forlenza.css-eqlu8i{font-size:small;padding-left:4px;} (Greg Forlenza, Gregory Forlenza)

Publication Activity (10 Years)

Top Topics

Top Venues

Gregory P Forlenza (Greg Forlenza, Gregory Forlenza)